Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 729; doi:10.1093/annonc/mdl103
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

H. C. Schouten

Home treatment for intensive hematological therapies: who will benefit?
Ann Oncol 17: 731-732; doi:10.1093/annonc/mdl095
[Extract] [Full Text] [PDF] [Request Permissions]

E. Aitini and G. L. Cetto

A good death for cancer patients: still a dream?
Annals of Oncology Advance Access published on March 24, 2006
Ann Oncol 17: 733-734; doi:10.1093/annonc/mdl061
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

K. L. Hennenfent and R. Govindan

Novel formulations of taxanes: a review. Old wine in a new bottle?
Annals of Oncology Advance Access published on December 19, 2005
Ann Oncol 17: 735-749; doi:10.1093/annonc/mdj100
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Curigliano, G. Spitaleri, E. Pietri, M. Rescigno, F. de Braud, A. Cardillo, E. Munzone, A. Rocca, G. Bonizzi, V. Brichard, L. Orlando, and A. Goldhirsch

Breast cancer vaccines: a clinical reality or fairy tale?
Annals of Oncology Advance Access published on November 17, 2005
Ann Oncol 17: 750-762; doi:10.1093/annonc/mdj083
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

original articles:

hematologic malignancies:

M. L. Savoie, T. J. Nevil, K. W. Song, D. L. Forrest, D. E. Hogge, S. H. Nantel, J. D. Shepherd, C. A. Smith, H. J. Sutherland, C. L. Toze, and J. C. Lavoie

Shifting to outpatient management of acute myeloid leukemia: a prospective experience
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 763-768; doi:10.1093/annonc/mdl011
[Abstract] [Full Text] [PDF] [Request Permissions]

A. J. M. Ferreri, E. Viale, M. Guidoboni, A. Giordano Resti, C. De Conciliis, L. Politi, A. A. Lettini, F. Sacchetti, R. Dolcetti, C. Doglioni, and M. Ponzoni

Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 769-772; doi:10.1093/annonc/mdl027
[Abstract] [Full Text] [PDF] [Request Permissions]

K. Last, L. Maharaj, J. Perry, S. Strauss, J. Fitzgibbon, T. A. Lister, and S. Joel

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours
Annals of Oncology Advance Access published on February 9, 2006
Ann Oncol 17: 773-779; doi:10.1093/annonc/mdl004
[Abstract] [Full Text] [PDF] [Request Permissions]

S. Wöhrer, U. Jaeger, K. Kletter, A. Becherer, A. Hauswirth, K. Turetschek, M. Raderer, and M. Hoffmann

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 780-784; doi:10.1093/annonc/mdl014
[Abstract] [Full Text] [PDF] [Request Permissions]

P. Das, A. K. Ng, C. C. Earle, P. M. Mauch, and K. M. Kuntz

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis
Annals of Oncology Advance Access published on February 24, 2006
Ann Oncol 17: 785-793; doi:10.1093/annonc/mdl023
[Abstract] [Full Text] [PDF] [Request Permissions]

L. Pagano, A. Gallamini, G. Trapè, L. Fianchi, D. Mattei, G. Todeschini, A. Spadea, S. Cinieri, E. Iannitto, M. Martelli, A. Nosari, E. Di Bona, M. E. Tosti, M. C. Petti, P. Falcucci, M. Montanaro, A. Pulsoni, L. M. Larocca, and G. Leone For the Intergruppo Italiano Linfomi

NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 794-800; doi:10.1093/annonc/mdl015
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

A. Glaus, Ch. Boehme, B. Thürlimann, T. Ruhstaller, S. F. Hsu Schmitz, R. Morant, H. J. Senn, and R. von Moos

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
Annals of Oncology Advance Access published on February 28, 2006
Ann Oncol 17: 801-806; doi:10.1093/annonc/mdl030
[Abstract] [Full Text] [PDF] [Request Permissions]

D. Crivellari, D. Lombardi, G. Corona, C. Massacesi, R. Talamini, R. Sorio, M. D. Magri, C. Lestuzzi, A. Lucenti, A. Veronesi, and G. Toffoli

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 807-812; doi:10.1093/annonc/mdl013
[Abstract] [Full Text] [PDF] [Request Permissions]

C. H. Yang, A. M. Gonzalez-Angulo, J. M. Reuben, D. J. Booser, L. Pusztai, S. Krishnamurthy, D. Esseltine, J. Stec, K. R. Broglio, R. Islam, G. N. Hortobagyi, and M. Cristofanilli

Bortezomib (VELCADE^®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Annals of Oncology Advance Access published on January 10, 2006
Ann Oncol 17: 813-817; doi:10.1093/annonc/mdj131
[Abstract] [Full Text] [PDF] [Request Permissions]

M. Dowsett, J. Houghton, C. Iden, J. Salter, J. Farndon, R. A'Hern, R. Sainsbury, and M. Baum

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 818-826; doi:10.1093/annonc/mdl016
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

F. Bonnetain, O. Bouché, P. Michel, C. Mariette, T. Conroy, D. Pezet, B. Roullet, J.-F. Seitz, B. Paillot, P. Arveux, C. Milan, and L. Bedenne

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 827-834; doi:10.1093/annonc/mdl033
[Abstract] [Full Text] [PDF] [Request Permissions]

B. Vincenzi, D. Santini, A. Russo, M. Silletta, M. Gavasci, F. Battistoni, G. Di Cuonzo, L. Rocci, N. Gebbia, and G. Tonini

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients
Annals of Oncology Advance Access published on February 28, 2006
Ann Oncol 17: 835-841; doi:10.1093/annonc/mdl031
[Abstract] [Full Text] [PDF] [Request Permissions]

B. Iacopetta, A. Russo, V. Bazan, G. Dardanoni, N. Gebbia, T. Soussi, D. Kerr, H. Elsaleh, R. Soong, D. Kandioler, E. Janschek, S. Kappel, M. Lung, C.-S. S. Leung, J. M. Ko, S. Yuen, J. Ho, S. Y. Leung, E. Crapez, J. Duffour, M. Ychou, D. T. Leahy, D. P. O'Donoghue, V. Agnese, S. Cascio, G. Di Fede, L. Chieco-Bianchi, R. Bertorelle, C. Belluco, W. Giaretti, P. Castagnola, E. Ricevuto, C. Ficorella, S. Bosari, C. D. Arizzi, M. Miyaki, M. Onda, E. Kampman, B. Diergaarde, J. Royds, R. A. Lothe, C. B. Diep, G. I. Meling, J. Ostrowski, L. Trzeciak, K. Guzinska-Ustymowicz, B. Zalewski, G. M. Capellá, V. Moreno, M. A. Peinado, C. Lönnroth, K. Lundholm, X. F. Sun, A. Jansson, H. Bouzourene, L.-L. Hsieh, R. Tang, D. R. Smith, T. G. Allen-Mersh, Z. A. J. Khan, A. J. Shorthouse, M. L. Silverman, S. Kato, and C. Ishioka

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 842-847; doi:10.1093/annonc/mdl035
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

P. Baas, N. van 't Hullenaar, J. Wagenaar, J. P. G. Kaajan, M. Koolen, M. Schrijver, N. Schlösser, and J. A. Burgers

Occupational asbestos exposure: how to deal with suspected mesothelioma cases—the Dutch approach
Annals of Oncology Advance Access published on February 24, 2006
Ann Oncol 17: 848-852; doi:10.1093/annonc/mdl021
[Abstract] [Full Text] [PDF] [Request Permissions]

oncology practice:

M. Costantini, G. Morasso, M. Montella, P. Borgia, R. Cecioni, M. Beccaro, E. Sguazzotti, and P. Bruzzi On behalf of the ISDOC Study Group

Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey
Annals of Oncology Advance Access published on March 21, 2006
Ann Oncol 17: 853-859; doi:10.1093/annonc/mdl028
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

T. K. Choueiri, T. Mekhail, T. E. Hutson, R. Ganapathi, G. E. Kelly, and R. M. Bukowski

Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 860-865; doi:10.1093/annonc/mdl010
[Abstract] [Full Text] [PDF] [Request Permissions]

H. Richly, B. F. Henning, P. Kupsch, K. Passarge, M. Grubert, R. A. Hilger, O. Christensen, E. Brendel, B. Schwartz, M. Ludwig, C. Flashar, R. Voigtmann, M. E. Scheulen, S. Seeber, and D. Strumberg

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors
Annals of Oncology Advance Access published on February 24, 2006
Ann Oncol 17: 866-873; doi:10.1093/annonc/mdl017
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

M. E. Bonneterre and J. Bonneterre

Reply to the article "A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model based cost-effectiveness analysis", by J. Norum et al. (Ann Oncol 2005; 16: 909–914)
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 875; doi:10.1093/annonc/mdj074
[Extract] [Full Text] [PDF] [Request Permissions]

Jan Norum

Reply to the Letter to the Editor, by J. Bonneterre and M. E. Bonneterre (Ann Oncol 2006; 17: 875)
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 875-876; doi:10.1093/annonc/mdj075
[Extract] [Full Text] [PDF] [Request Permissions]

D. Tassinari, B. Poggi, M. Fantini, E. Tamburini, S. Nicoletti, and S. Sartori

Cost–opportunity analysis in clinical oncology: from the ‘wild far-west’ to a correct integration of the disciplines, avoiding the ‘war of the worlds’
Annals of Oncology Advance Access published on November 29, 2005
Ann Oncol 17: 876-877; doi:10.1093/annonc/mdj086
[Extract] [Full Text] [PDF] [Request Permissions]

G. Bocci, M. Tuccori, U. Emmenegger, V. Liguori, A. Falcone, R. S. Kerbel, and M. Del Tacca

Reply to the Letter to the Editor on ‘Cost-opportunity analysis in clinical oncology: from the "wild far-west" to a correct integration of the disciplines, avoiding the "war of the worlds"’, by D. Tassinari et al. (Ann Oncol 2006; 17: 876)
Annals of Oncology Advance Access published on November 29, 2005
Ann Oncol 17: 877-878; doi:10.1093/annonc/mdj088
[Extract] [Full Text] [PDF] [Request Permissions]

M. Colleoni, S. Gelber, and A. Goldhirsch

Reply to the Letter to the Editor on ‘Cost–opportunity analysis in clinical oncology: from the "wild far-west" to a correct integration of the disciplines, avoiding the "war of the worlds"’, by D. Tassinari et al. (Ann Oncol 2006; 17: 877)
Annals of Oncology Advance Access published on November 29, 2005
Ann Oncol 17: 878; doi:10.1093/annonc/mdj087
[Extract] [Full Text] [PDF] [Request Permissions]

A. U. Buzdar

St Gallen guidelines: aromatase inhibitors recommended by name for adjuvant therapy
Ann Oncol 17: 878-879; doi:10.1093/annonc/mdj093
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.